250 related articles for article (PubMed ID: 28899762)
41. Identification of neuronal and angiogenic growth factors in an in vitro blood-brain barrier model system: Relevance in barrier integrity and tight junction formation and complexity.
Freese C; Hanada S; Fallier-Becker P; Kirkpatrick CJ; Unger RE
Microvasc Res; 2017 May; 111():1-11. PubMed ID: 27988246
[TBL] [Abstract][Full Text] [Related]
42. Gold Nanoparticles Increase Endothelial Paracellular Permeability by Altering Components of Endothelial Tight Junctions, and Increase Blood-Brain Barrier Permeability in Mice.
Li CH; Shyu MK; Jhan C; Cheng YW; Tsai CH; Liu CW; Lee CC; Chen RM; Kang JJ
Toxicol Sci; 2015 Nov; 148(1):192-203. PubMed ID: 26272951
[TBL] [Abstract][Full Text] [Related]
43. Current Strategies for Brain Drug Delivery.
Dong X
Theranostics; 2018; 8(6):1481-1493. PubMed ID: 29556336
[TBL] [Abstract][Full Text] [Related]
44. Quantitative analysis of nanoparticle transport through in vitro blood-brain barrier models.
Berg C
Tissue Barriers; 2016; 4(1):e1143545. PubMed ID: 27141425
[TBL] [Abstract][Full Text] [Related]
45. The critical component to establish in vitro BBB model: Pericyte.
Lai CH; Kuo KH
Brain Res Brain Res Rev; 2005 Dec; 50(2):258-65. PubMed ID: 16199092
[TBL] [Abstract][Full Text] [Related]
46. Biodegradable polyanhydride-based nanomedicines for blood to brain drug delivery.
Brenza TM; Schlichtmann BW; Bhargavan B; Vela Ramirez JE; Nelson RD; Panthani MG; McMillan JM; Kalyanaraman B; Gendelman HE; Anantharam V; Kanthasamy AG; Mallapragada SK; Narasimhan B; Kanmogne GD
J Biomed Mater Res A; 2018 Nov; 106(11):2881-2890. PubMed ID: 30369055
[TBL] [Abstract][Full Text] [Related]
47. Heterogeneity of the blood-brain barrier.
Wilhelm I; Nyúl-Tóth Á; Suciu M; Hermenean A; Krizbai IA
Tissue Barriers; 2016; 4(1):e1143544. PubMed ID: 27141424
[TBL] [Abstract][Full Text] [Related]
48. Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity.
Rempe R; Cramer S; Hüwel S; Galla HJ
Biochem Biophys Res Commun; 2011 Mar; 406(1):64-9. PubMed ID: 21295549
[TBL] [Abstract][Full Text] [Related]
49. Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier.
Lu W; Tan YZ; Hu KL; Jiang XG
Int J Pharm; 2005 May; 295(1-2):247-60. PubMed ID: 15848009
[TBL] [Abstract][Full Text] [Related]
50. Organization of Endothelial Cells, Pericytes, and Astrocytes into a 3D Microfluidic in Vitro Model of the Blood-Brain Barrier.
Wang JD; Khafagy el-S; Khanafer K; Takayama S; ElSayed ME
Mol Pharm; 2016 Mar; 13(3):895-906. PubMed ID: 26751280
[TBL] [Abstract][Full Text] [Related]
51. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
[TBL] [Abstract][Full Text] [Related]
52. Blood brain barrier: An overview on strategies in drug delivery, realistic in vitro modeling and in vivo live tracking.
Pandey PK; Sharma AK; Gupta U
Tissue Barriers; 2016; 4(1):e1129476. PubMed ID: 27141418
[TBL] [Abstract][Full Text] [Related]
53. Biodegradable Nanoparticles for Delivery of Therapeutics in CNS Infection.
DeMarino C; Schwab A; Pleet M; Mathiesen A; Friedman J; El-Hage N; Kashanchi F
J Neuroimmune Pharmacol; 2017 Mar; 12(1):31-50. PubMed ID: 27372507
[TBL] [Abstract][Full Text] [Related]
54. Methylmethacrylate-sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood-brain barrier.
Kuo YC; Lee CL
Colloids Surf B Biointerfaces; 2012 Feb; 90():75-82. PubMed ID: 22024400
[TBL] [Abstract][Full Text] [Related]
55. Nanotechnologies: a strategy to overcome blood-brain barrier.
De Rosa G; Salzano G; Caraglia M; Abbruzzese A
Curr Drug Metab; 2012 Jan; 13(1):61-9. PubMed ID: 22292810
[TBL] [Abstract][Full Text] [Related]
56. Uptake and transport of superparamagnetic iron oxide nanoparticles through human brain capillary endothelial cells.
Thomsen LB; Linemann T; Pondman KM; Lichota J; Kim KS; Pieters RJ; Visser GM; Moos T
ACS Chem Neurosci; 2013 Oct; 4(10):1352-60. PubMed ID: 23919894
[TBL] [Abstract][Full Text] [Related]
57. Salvaging brain ischemia by increasing neuroprotectant uptake via nanoagonist mediated blood brain barrier permeability enhancement.
Zheng S; Bai YY; Liu Y; Gao X; Li Y; Changyi Y; Wang Y; Chang D; Ju S; Li C
Biomaterials; 2015 Oct; 66():9-20. PubMed ID: 26188608
[TBL] [Abstract][Full Text] [Related]
58. Delivery of Dual Drug Loaded Lipid Based Nanoparticles across the Blood-Brain Barrier Impart Enhanced Neuroprotection in a Rotenone Induced Mouse Model of Parkinson's Disease.
Kundu P; Das M; Tripathy K; Sahoo SK
ACS Chem Neurosci; 2016 Dec; 7(12):1658-1670. PubMed ID: 27642670
[TBL] [Abstract][Full Text] [Related]
59. Nanomaterial-based blood-brain-barrier (BBB) crossing strategies.
Xie J; Shen Z; Anraku Y; Kataoka K; Chen X
Biomaterials; 2019 Dec; 224():119491. PubMed ID: 31546096
[TBL] [Abstract][Full Text] [Related]
60. Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury.
Dimitrijevic OB; Stamatovic SM; Keep RF; Andjelkovic AV
J Cereb Blood Flow Metab; 2006 Jun; 26(6):797-810. PubMed ID: 16192992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]